Analysis results from the second server showed that the expression of RACGAP1 negatively influenced OS, distant metastasis-free survival (DMFS), and relapse-free survival (RFS) (p < 0.001) (Figure 4A) in breast cancer patients. Here, RACGAP1 is linked to breast carcinoma.